XML 100 R89.htm IDEA: XBRL DOCUMENT v3.21.2
SEGMENT REPORTING (Details 1)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues and Concentration Risk 100.00% 100.00% 100.00% 100.00%
Other sales less than 10% [Member]        
Revenues and Concentration Risk 1.00% 2.00% 1.00% 2.00%
CureFilm? sales [Member]        
Revenues and Concentration Risk 21.00% 98.00% 14.00% 75.00%
Research & Development services [Member]        
Revenues and Concentration Risk     1.00% 23.00%
Product sales - CBD [Member]        
Revenues and Concentration Risk 78.00%   77.00%  
Product sales - PPE [Member]        
Revenues and Concentration Risk     7.00%